One key area of interest in cardiovascular endocrinology is the impact of metabolic syndrome on cardiovascular health. Metabolic syndrome, characterized by a cluster of conditions such as obesity, insulin resistance, and dyslipidemia, significantly increases the risk of cardiovascular diseases. Cardiovascular endocrinologists study the intricate relationships between adipose tissue, insulin signaling, and inflammation, exploring how these factors contribute to the development of atherosclerosis and cardiovascular complications. Research in cardiovascular endocrinology also delves into hormonal regulation of blood pressure, focusing on the role of aldosterone, renin-angiotensin-aldosterone system (RAAS), and other hormones in maintaining cardiovascular homeostasis. The integration of endocrinology and cardiovascular medicine highlights the need for a comprehensive understanding of the interactions between hormonal regulation and cardiovascular function, paving the way for targeted therapies and personalized approaches to address the multifaceted aspects of cardiovascular health.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China